ReviewPharmacology & therapeutics2020
PARP inhibition in the ovarian cancer patient: Current approvals and future directions.
Katherine C Kurnit et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papertrialcites it